Integral Health Asset Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Integral Health Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $1.78 Million - $2.21 Million	-125,000 Closed	0 $0
Q2 2021 Aug 30, 2021	SELL	$9.5 - $17.24 $1.19 Million - $2.16 Million	-125,000 Reduced 50.0%	125,000 $1.98 Million
Q2 2021 Aug 13, 2021	SELL	$9.5 - $17.24 $1.43 Million - $2.59 Million	-150,000 Reduced 37.5%	250,000 $3.95 Million
Q1 2021 May 10, 2021	BUY	$7.37 - $13.61 $2.95 Million - $5.44 Million	400,000 New	400,000 $4.07 Million

260

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.